Stereotactic Body Radiotherapy in the Treatment of Advanced Adenocarcinoma of the Pancreas

Abstract

SBRT is feasible, with minimal grade ≥3 toxicity. The overall FFLP rate for all patients was 64.8%, comparable to rates with external beam radiotherapy. This shorter treatment course can be delivered without delay in adjuvant systemic therapy.